Chemed Co. (NYSE:CHE) announced a quarterly dividend on Friday, November 2nd, RTT News reports. Stockholders of record on Monday, November 12th will be paid a dividend of 0.30 per share on Monday, December 3rd. This represents a $1.20 annualized dividend and a dividend yield of 0.39%.
Chemed has increased its dividend by an average of 8.7% per year over the last three years and has increased its dividend annually for the last 9 consecutive years. Chemed has a payout ratio of 10.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Chemed to earn $12.29 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 9.8%.
Shares of NYSE CHE opened at $306.93 on Friday. The stock has a market cap of $4.90 billion, a P/E ratio of 57.26, a P/E/G ratio of 2.73 and a beta of 1.22. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.01 and a current ratio of 1.14. Chemed has a 12-month low of $227.14 and a 12-month high of $335.99.
Chemed (NYSE:CHE) last issued its quarterly earnings results on Monday, October 29th. The company reported $3.07 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.80 by $0.27. The business had revenue of $444.15 million for the quarter, compared to the consensus estimate of $445.16 million. Chemed had a net margin of 11.73% and a return on equity of 35.13%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.15 EPS. On average, sell-side analysts forecast that Chemed will post 11.41 earnings per share for the current fiscal year.
Several research analysts recently issued reports on CHE shares. ValuEngine downgraded shares of Chemed from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 2nd. Zacks Investment Research upgraded shares of Chemed from a “hold” rating to a “buy” rating and set a $350.00 price target on the stock in a research report on Tuesday, July 31st. Bank of America started coverage on shares of Chemed in a research report on Friday, October 12th. They set a “buy” rating and a $390.00 price target on the stock. Finally, Royal Bank of Canada upped their price target on shares of Chemed to $321.00 and gave the stock a “market perform” rating in a research report on Monday, July 30th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Chemed currently has a consensus rating of “Buy” and an average price target of $334.00.
In other Chemed news, insider Kevin J. Mcnamara sold 4,000 shares of the business’s stock in a transaction dated Thursday, August 23rd. The stock was sold at an average price of $319.50, for a total transaction of $1,278,000.00. Following the completion of the sale, the insider now directly owns 139,491 shares of the company’s stock, valued at approximately $44,567,374.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Donald E. Saunders sold 300 shares of the business’s stock in a transaction dated Monday, August 20th. The stock was sold at an average price of $319.22, for a total value of $95,766.00. Following the sale, the director now directly owns 8,701 shares of the company’s stock, valued at $2,777,533.22. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,006 shares of company stock worth $1,923,098. 4.90% of the stock is owned by corporate insiders.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.
Recommended Story: What is Liquidity?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.